Share
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Annals of Hepatology
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
Ana Barreira-Díaz, Mar Riveiro-Barciela, Eva María Fernández-Bonilla, Vanesa Bernal, Agustín Castiella, Marta Casado-Martín, Carolina Delgado, María-Carlota Londoño, Álvaro Díaz-González, Indhira Pérez-Medrano, Andrés Conthe, Margarita Sala, Beatriz Mateos, Judith Gómez-Camarero, Dolores Antón-Conejero, Carmen Del Pozo-Calzada, Francisca Cuenca, Ares Villagrasa-Vilella, Magdalena Salcedo
10.1016/j.aohep.2024.101489
Full text access
Available online 30 April 2024
Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
Shuguang Pan, Ying Hu, Lang Gan, Jiejuan Lai, Ping Zheng, YuJun Zhang, Ling Shuai, Yan Jiang, Mo Chen, Junping Wang, Yu He
10.1016/j.aohep.2023.101279
Ann Hepatol. 2024;29:
Full text access
P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
Samael Rodríguez, Rebeca Rosas, Angel Omar Vazquez, Ivonne Palacios, Ricardo De la Rosa, Rebeca Escutia, Josep Jiménez, Luis Felipe Jave, Arturo Santos, Ana Sandoval, Juan Armendariz
10.1016/j.aohep.2023.101189
Ann Hepatol. 2024;29 Supl 1:
Full text access
O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Alexandre Araujo, Sophia Andreola, Leonardo Cezimbra, Vitoria Dal Agnol, Hugo Cheinquer, Jeronimo De Conto, Roberta Cabral, Carlos Thadeu, Cleber Rosito, Marcio Chedid, Mário Reis Álvares-Da-Silva
10.1016/j.aohep.2023.101252
Ann Hepatol. 2024;29 Supl 1:
Full text access
P- 17 LIVER TESTS ABNORMALITIES AS PROGNOSTIC MARKERS OF DEATH IN PATIENTS HOSPITALISED BY COVID-19. A COHORT STUDY
Andrés Fernando Rodríguez, Sergio Mauricio Moreno, Camilo Andrés Duarte
10.1016/j.aohep.2023.101204
Ann Hepatol. 2024;29 Supl 1:
Full text access
P-51 SERUM MICRORNA EXPRESSION ACCORDING TO THE PRESENCE OF LIVER DISEASE AND SARS-CoV-2 INFECTION
Lucas Lima Da, Luciane Almeida Amado, Otacilio Da Cruz, Wagner Luis Da Costa Nunes Pimentel, Vanessa Duarte, Claudia Alexandra Pontes, Lia Laura, Vanessa Salete, Barbara Vieira, Livia Melo
10.1016/j.aohep.2023.101238
Ann Hepatol. 2024;29 Supl 1:
Full text access
P-10 THE EFFECTS OF CHILEAN RESPONSE TO COVID-19 ON ALCOHOL CONSUMERS: A NATURAL POLICY EXPERIMENT
María Jesús Fuenzalida, Óscar Corsi, Valentina Cox, Luis Antonio Díaz, Juan Pablo Arab, Paula Margozzini, José Marín
10.1016/j.aohep.2023.101197
Ann Hepatol. 2024;29 Supl 1:
Full text access
OP-2 ANALYSIS OF THE GENETIC DIVERSITY OF HEPATITIS DELTA VIRUS CIRCULATING IN BRAZIL BETWEEN 2013 AND 2021 AND ITS RELATIONSHIP WITH HEPATITIS B VIRUS
Giovana Angelice, Tairine de Barros, Livia Villar, Bárbara do Lago, Francisco Mello
10.1016/j.aohep.2023.101275
Ann Hepatol. 2024;29 Supl 1:
Full text access
Regulation of TGF-β1, 2, and 3 and IL-10 at systemic level in chronic liver disease
Marisela Hernandez-Santillan, Abigail Hernandez-Barragan, Moises Martínez-Castillo, Zaira Medina-Ávila, Harumi Reséndiz-García, Erik Robledo-Ramírez, Yadira Guizar-Alcántara, Amanda Álvarez-Rodea, Danna Mercado-Herrera, María F. Higuera-De La Tijera, José L. Pérez-Hernández, Daniel Santana-Vargas, Gabriela Gutiérrez-Reyes
10.1016/j.aohep.2024.101425
Ann Hepatol. 2024;29 Supl 2:
Full text access
Hepatic injury biomarkers in COVID-19
Diana K. Tapia-Calderón, Ana I. Tornel-Avelar, Francisco A. Félix-Téllez, Lydia A. Mercado-Jáuregui, Liliana E. Ramos-Villalobos, Bladimir Diaz-Villavicencio, Monserrat Lazcano-Becerra, Rodrigo Escobedo-Sánchez, Edgar S. García-Jiménez, José A. Velarde-Ruiz Velasco
10.1016/j.aohep.2024.101459
Ann Hepatol. 2024;29 Supl 2:
Full text access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
